Violet Therapeutics

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Cambridge, Massachusetts, United States

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Violet Therapeutics

Based in Cambridge, Massachusetts, Violet Therapeutics is a medtech company and cell-to-cell interaction solutions provider.Explore more
Popular SearchesViolet TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Is Violet Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Violet Therapeutics

Compare insights from companies similar to Violet Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Violet Therapeutics

<$5M
11-50
Private
$10.6M
2021
N/A
$33.8M
51-200
Private
$300M
2021
GS
Gregory SieczkiewiczInterim Chief Legal Officer
$8.5M
11-50
Private
$270M
2022
MD
Mark DoucetteVice President, Controller
$6.3M
11-50
Private
$50M
2022
Rahul Kakkar, President &  Chief & Executive Officer at Quotient Therapeutics
Rahul KakkarPresident & Chief & Executive Officer
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2021
MS
Marie SchickPrincipal & Co-Founder
<$5M
1-10
Private
<$5M
2015
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Violet Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Violet Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Violet Therapeutics.

Violet Therapeutics financials insights

Gather financial insights about Violet Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2023

Angel/Seed

$10.6M

See All Violet Therapeutics's Financials Insights

Top Business Services Companies

Frequently Asked Questions Regarding Violet Therapeutics

What is Violet Therapeutics's official website?
Violet Therapeutics's official website is www.violet-therapeutics.com
What is Violet Therapeutics's Revenue?
Violet Therapeutics's revenue is <$5 Million
What is Violet Therapeutics's SIC code?
Violet Therapeutics's SIC: 87,873
What is Violet Therapeutics's NAICS code?
Violet Therapeutics's NAICS: 54,541
How many employees does Violet Therapeutics have?
Violet Therapeutics has 11-50 employees
What industry does Violet Therapeutics belong to?
Violet Therapeutics is in the industry of: Business Services, Research & Development
What is Violet Therapeutics competition?
Violet Therapeutics top competitors include: Orbital Therapeutics, Schick Creative, Quotient Therapeutics, ReNAgade Therapeutics
What does Violet Therapeutics do?

Based in Cambridge, Massachusetts, Violet Therapeutics is a medtech company and cell-to-cell interaction solutions provider.... Read More

Who invested in Violet Therapeutics?
Violet Therapeutics has 2 investors including Dementia Discovery Fund and Utec.
Is Violet Therapeutics a public company?
Violet Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Violet Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.